Sonoma Pharmaceuticals, Inc. (SNOA) Misses Q2 EPS by 54c

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q2 EPS of ($0.59), $0.54 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $3.9 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• Bending Spoons closes $1.25B term loan add-on to fund Miro deal
• Boeing and Bell Boeing receive defense contracts totaling $56.4M